DEXCOM, INC. Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)
DEXCOM, INC. (DXCM) had Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) of $0 as of 2013-03-31, per its 10-Q filed 2013-05-01.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 · last filed 2013-05-01
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $0.00.
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $0.00.
- 2012-09-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $1.00K.
- 2012-06-30: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $9.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2013-03-31 | $0.00 10-Q · filed 2013-05-01 | |
| 2012-12-31 | $0.00 10-Q · filed 2013-05-01 | |
| 2012-09-30 | $1.00K 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $9.00K 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $8.00K 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $0.00 10-K · filed 2013-02-21 | $14.00K 10-K · filed 2012-02-23 |
| 2010-12-31 | $12.00K 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |